Overview


According to FutureWise analysis the market for Transcatheter Heart Valve Replacement (TAVI) in 2023 is US$ 6.56 billion, and is expected to reach US$ 20.08 billion by 2031 at a CAGR of 15.00%.

Transcatheter heart valves are in high demand due to technological advances in surgical techniques. A favorable reimbursement scenario and growing interest from manufacturers are also contributing to higher transcatheter heart valve sales. Recently, the global transcatheter heart valve replacement market has seen increased product development initiatives by companies, which has contributed to an increase in market share. There will be a tremendous surge in sales of transcatheter pulmonary valves as they are in high demand as are used to treat patients with narrowed and leaky pulmonary valves. Transcatheter heart valves are also useful for reducing patients' need for heart surgeries over the course of their lives, thereby increasing their sales. Transcatheter heart valve demand is thereby driven by these factors, driving segment growth in the forecast period. Due to increased research investment by major manufacturers in order to enter into strategic collaborations, transcatheter heart valve replacement is emerging as a new market frontier. A new product designed to replace a transcatheter heart valve is expected to boost sales of transcatheter heart valves. With people rapidly shifting towards minimally invasive treatment options, the introduction of transcatheter technology spikes transcatheter heart valve demand. As an example, Medtronic recently launched a transcatheter heart valve replacement system called Evolut PRO+. In addition, sales of transcatheter heart valves are expected to skyrocket as proven clinical studies show transcatheter heart valves are safer than surgical valves, and there are fewer complications.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Transcatheter Heart Valve Replacement (TAVI) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Transcatheter Heart Valve Replacement (TAVI) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • 4C Medical Technologies
  • Abbott
  • Boston Scientific
  • Edwards Lifesciences
  • HighLife Medical
  • JC Medical
  • LivaNova
  • Medtronic plc.
  • Neovasc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Transcatheter Aortic Valve Replacement
  • Transcatheter Mitral Valve Repair and Replacement
  • Transcatheter Pulmonary Valve Replacement

By Surgical Approach

  • Transfemoral Approach
  • Transapical Approach
  • Others

By Application

  • Aortic Valvular Heart Disease
    • Aortic Valve Stenosis
    • Aortic Valve Regurgitation
  • Mitral Valvular Heart Disease
    • Mitral Valve Stenosis
    • Mitral Valve Regurgitation
  • Pulmonary Valvular Heart Disease

By End User

  • Hospitals
  • Cath Labs

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Transcatheter Heart Valve Replacement (TAVI) Market By Product, By Surgical Approach, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Transcatheter Heart Valve Replacement (TAVI) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Transcatheter Heart Valve Replacement (TAVI) Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Transcatheter Heart Valve Replacement (TAVI) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Transcatheter Heart Valve Replacement (TAVI) Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Transcatheter Aortic Valve Replacement
        2. Transcatheter Mitral Valve Repair and Replacement
        3. Transcatheter Pulmonary Valve Replacement

  • 8.   Transcatheter Heart Valve Replacement (TAVI) Market, By Surgical Approach Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Transfemoral Approach
        2. Transapical Approach
        3. Others

  • 9.   Transcatheter Heart Valve Replacement (TAVI) Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Aortic Valvular Heart Disease
         1.1. Aortic Valve Stenosis
         1.2. Aortic Valve Regurgitation
        2. Mitral Valvular Heart Disease
         2.1. Mitral Valve Stenosis
         2.2. Mitral Valve Regurgitation
        3. Pulmonary Valvular Heart Disease

  • 10.   Transcatheter Heart Valve Replacement (TAVI) Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Cath Labs

  • 11.   North America Transcatheter Heart Valve Replacement (TAVI) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Transcatheter Heart Valve Replacement (TAVI) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Transcatheter Heart Valve Replacement (TAVI) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Transcatheter Heart Valve Replacement (TAVI) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. 4C Medical Technologies
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Edwards Lifesciences
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. HighLife Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. JC Medical
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. LivaNova
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic plc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Neovasc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients